Literature DB >> 11730013

Electrophoretic mobility shift scanning using an automated infrared DNA sequencer.

M Sano1, A Ohyama, K Takase, M Yamamoto, M Machida.   

Abstract

Electrophoretic mobility shift assay (EMSA) is widely used in the study of sequence-specific DNA-binding proteins, including transcription factors and mismatch binding proteins. We have established a non-radioisotope-based protocol for EMSA that features an automated DNA sequencer with an infrared fluorescent dye (IRDye) detection unit. Our modification of the elec- trophoresis unit, which includes cooling the gel plates with a reduced well-to-read length, has made it possible to detect shifted bands within 1 h. Further, we have developed a rapid ligation-based method for generating IRDye-labeled probes with an approximately 60% cost reduction. This method has the advantages of real-time scanning, stability of labeled probes, and better safety associated with nonradioactive methods of detection. Analysis of a promoter from an industrially important filamentous fungus, Aspergillus oryzae, in a prototype experiment revealed that the method we describe has potential for use in systematic scanning and identification of the functionally important elements to which cellular factors bind in a sequence-specific manner.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11730013     DOI: 10.2144/01315st06

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  2 in total

1.  Mitochondrial and nuclear accumulation of the transcription factor ATFS-1 promotes OXPHOS recovery during the UPR(mt).

Authors:  Amrita M Nargund; Christopher J Fiorese; Mark W Pellegrino; Pan Deng; Cole M Haynes
Journal:  Mol Cell       Date:  2015-03-12       Impact factor: 17.970

2.  A 96-well DNase I footprinting screen for drug-DNA interactions.

Authors:  Tom Ellis; David A Evans; Christopher R H Martin; John A Hartley
Journal:  Nucleic Acids Res       Date:  2007-06-22       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.